Seres Therapeutics, Inc.
For the period ended Jun 30, 2025. Filed Aug 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 6, 2025
MCRB$1.70-14.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| Incorporated by Reference · Filed/ | ||||||
|---|---|---|---|---|---|---|
| ExhibitNumber | Exhibit Description | Form | File No. | Exhibit | FilingDate | FurnishedHerewith |
| 3.1 | Restated Certificate of Incorporation, filed on July 1, 2015 | 8-K | 001-37465 | 3.1 | 7/1/15 | |
| 3.2 | Certificate of Amendment to Restated Certificate of Incorporation of Seres Therapeutics, Inc., dated June 27, 2023 | 8-K | 001-37465 | 3.1 | 6/28/23 | |
| 3.3 | Certificate of Amendment to Restated Certificate of Incorporation of Seres Therapeutics, Inc., dated April 5, 2024 | 8-K | 001-37465 | 3.1 | 4/8/24 | |
| 3.4 | Certificate of Amendment to Restated Certificate of Incorporation of Seres Therapeutics, Inc., dated April 21, 2025 | 8-K | 001-37465 | 3.1 | 4/22/25 | |
| 3.5 | Amended and Restated Bylaws | 8-K | 001-37465 | 3.1 | 1/2/24 | |
| 10.1 | Letter Agreement, dated July 21, 2025, by and between the Company and Eric Shaff | * | ||||
| 10.2 | Letter Agreement, dated July 21, 2025, by and between the Company and Marella Thorell | * | ||||
| 10.3 | Letter Agreement, dated July 21, 2025, by and between the Company and Thomas DesRosier | * | ||||
| 31.1 | Rule 13a-14(a)/15d-14(a) Certification of Co-Chief Executive Officer and Chief Financial Officer | * | ||||
| 31.2 | Rule 13a-14(a)/15d-14(a) Certification of Co-Chief Executive Officer | * | ||||
| 32.1 | Section 1350 Certification of Co-Chief Executive Officer and Chief Financial Officer | ** | ||||
| 32.2 | Section 1350 Certification of Co-Chief Executive Officer | ** | ||||
| 101.INS | Inline XBRL Instance Document - the Instance Document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document | * | ||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document | * | ||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | * | ||||
- Filed herewith.
** Furnished herewith.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.